These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7484983)
1. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Covi L; Hess JM; Kreiter NA; Haertzen CA Am J Drug Alcohol Abuse; 1995 Aug; 21(3):327-44. PubMed ID: 7484983 [TBL] [Abstract][Full Text] [Related]
2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208 [TBL] [Abstract][Full Text] [Related]
3. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. Krupitsky EM; Zvartau EE; Masalov DV; Tsoy MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE J Subst Abuse Treat; 2006 Dec; 31(4):319-28. PubMed ID: 17084785 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo]. Lemoine P; Touchon J; Billardon M Encephale; 1997; 23(4):290-9. PubMed ID: 9417395 [TBL] [Abstract][Full Text] [Related]
5. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior. Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873 [TBL] [Abstract][Full Text] [Related]
6. [Fluoxetine dependence and tolerance. Apropos of a case]. Menecier P; Menecier-Ossia L; Bern P Encephale; 1997; 23(5):400-1. PubMed ID: 9453934 [TBL] [Abstract][Full Text] [Related]
7. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. McKay JR; Lynch KG; Shepard DS; Pettinati HM Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297 [TBL] [Abstract][Full Text] [Related]
8. Fluoxetine alters the effects of intravenous cocaine in humans. Walsh SL; Preston KL; Sullivan JT; Fromme R; Bigelow GE J Clin Psychopharmacol; 1994 Dec; 14(6):396-407. PubMed ID: 7884020 [TBL] [Abstract][Full Text] [Related]
9. Continuity of care and desipramine in primary cocaine abusers. Hall SM; Tunis S; Triffleman E; Banys P; Clark HW; Tusel D; Stewart P; Presti D J Nerv Ment Dis; 1994 Oct; 182(10):570-5. PubMed ID: 7931205 [TBL] [Abstract][Full Text] [Related]
10. [Toxic tricyclic drug plasma level caused by fluoxetine]. Hambrecht M Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758 [TBL] [Abstract][Full Text] [Related]
11. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. Fisch MJ; Loehrer PJ; Kristeller J; Passik S; Jung SH; Shen J; Arquette MA; Brames MJ; Einhorn LH; J Clin Oncol; 2003 May; 21(10):1937-43. PubMed ID: 12743146 [TBL] [Abstract][Full Text] [Related]
13. DHEAS and POMS measures identify cocaine dependence treatment outcome. Wilkins JN; Majewska MD; Van Gorp W; Li SH; Hinken C; Plotkin D; Setoda D Psychoneuroendocrinology; 2005 Jan; 30(1):18-28. PubMed ID: 15358439 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine once every third day in the treatment of major depressive disorder. Tural U; Onder E Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Nemeroff CB; Thase ME; J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158 [TBL] [Abstract][Full Text] [Related]
16. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960 [TBL] [Abstract][Full Text] [Related]
17. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms. Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347 [TBL] [Abstract][Full Text] [Related]
18. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study. Martenyi F; Brown EB; Caldwell CD J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240 [TBL] [Abstract][Full Text] [Related]
19. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. Batki SL; Manfredi LB; Jacob P; Jones RT J Clin Psychopharmacol; 1993 Aug; 13(4):243-50. PubMed ID: 8376611 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]